openPR Logo
Press release

Alzheimer’s Disease Diagnostic Market Share, Trend, Segmentation and Forecast to 2026 - Axon Neuroscience, Koninklijke Philips N.V., TauRx, Siemens AG

Axiom Market Research & Consulting

Axiom Market Research & Consulting

What is Alzheimer’s Disease Diagnostic?

There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2016, an estimated 5.4 million Americans of all ages have Alzheimer's disease. One in nine people aged 65 and above has Alzheimer's disease. By 2050, the number of people aged 65 and above affected with Alzheimer's disease is expected to nearly triple, from 5.2 million to an expected 13.8 million, excluding the development of medical advances to avert or cure the disease. Similarly, according to alzheimer’s disease International in 2015, there are an estimated 46.8 million people worldwide living with dementia and is further expected to grow in future. Thus, there is an increasing in the demand for Alzheimer’s diagnostics worldwide.

New York, October, 2020: Axiom Market Research & Consulting™ added a report on global Alzheimer’s Disease Diagnostic which includes study on various market segments across various countries of key regions across the globe. Post COVID19 pandemic impressive growth anticipated for this market. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the Alzheimer’s Disease Diagnostic market.

Get Sample PDF Copy @ https://bit.ly/3lp4jmN

Major Players in Alzheimer’s Disease Diagnostic Market

The key companies in the alzheimer’s diagnostic market are Axon Neuroscience, Koninklijke Philips N.V., TauRx, Siemens AG, F. Hoffmann La Roche AG, GE Healthcare, navidea biopharmaceuticals, Treventis Corporation, Eli Lilly, Cognition Therapeutics Inc. and Neuro-Bio Ltd (UK). Foremost companies have invested huge capital in mergers & acquisitions and research & development activities to develop advanced products in the market.

Covid-19 Impact Analysis on Alzheimer’s Disease Diagnostic Market

The global pandemic of Coronavirus (COVID-19) has triggered stock market unpredictability, tight border controls, and worldwide lockdown, leading the aesthetic industry, as well as large companies and governments, to restock supply chains. The whole world is experiencing severe impact on social and financial sectors, and all global industries are facing challenges during the COVID-19 pandemic. The exclusive COVID-19 Impact Analysis report by Axiom MRC explores the outbreak of COVID-19, its impact on the global and regional economies, and its implications on the healthcare sector. The report studies the effect of the pandemic on the global economy by evaluating factors like consumption, GDP, business investment, key players marketing strategies, key supply and demand-side factors, epidemiological swing factors, inventory, and governmental policies & decisions.

Alzheimer’s Disease Diagnostic Market Segmental Highlights

Axiom has better understanding of various market segments due to its in-depth value chain analysis. Market size and forecast for the major market segments in terms of value and volume for the forecast period 2020 to 2026 presented in the report

Purchase This Report @ https://bit.ly/3iBs2hN

Alzheimer’s Disease Diagnostic Market Regional Analysis

This study includes market size, share trend, competitive intelligence of developed markets, growth markets and niche regions/countries of:
• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

Research objectives and key highlights of the market study:-

• Comprehensive study with key countries of North America, Europe, APAC, Middle East & Africa and Latin America

• Market data share in terms of revenue (value) and scope of customization as per the need

• Detailed and comprehensive segmentation of the market to provide value added information to meet business goals

• Impact analysis of COVID-19 Pandemic on the global Alzheimer’s Disease Diagnostic market is studied in detail to provide you current and future market size and forecast

• Large number of key industry participants are interviewed to validate and understand current market trends

Contact Us:
Ganesh Sai
United States
3 Germay Dr. Ste 4 - 4666
Wilmington DE 19804
U.S.:- + 1 (845) 875-9786
U.K.:- + 44 (0) 20 3286 9707
Email: sales@axiommrc.com

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc.

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 700+ Market Research Projects, 2100+ Data Analytics Projects, 260+ Business Support Projects and has a 400+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

For more information, visit Axiom Market Research & Consulting™ at www.axiommrc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer’s Disease Diagnostic Market Share, Trend, Segmentation and Forecast to 2026 - Axon Neuroscience, Koninklijke Philips N.V., TauRx, Siemens AG here

News-ID: 2150513 • Views:

More Releases from Axiom Market Research & Consulting

Increasing investments in the development of renewable energy and upgrading of existing metro lines across the globe are expected to fuel the growth of DC Switchgear Industry
Increasing investments in the development of renewable energy and upgrading of e …
DC switchgear Market is anticipated to grow at a CAGR of 5.90% from 2022 to 2029 Switchgear is a group of electrical devices that includes fuses, circuit breakers, and electrical disconnect switches. They are used to protect, monitor, control, and isolate electrical equipment. A DC Switchgear refers to a type of electrical switchgear that is used for direct current (DC) applications. DC Switchgear is used in a variety of DC power
Bioreactors and Fermenters Market Insights, Trends, Outlook, and Opportunity Ana …
Axiom Market Research & Consulting published a report which covers detailed analysis of key drivers and restricting factors, value chain analysis, economic impact of Bioreactors and Fermenters market, GDP impact and competitive landscape backed by strategic outlook of each company. the global Bioreactors and Fermenters market is projected to grow at an impressive CAGR over the forecast period of 2023 to 2029. the global market is estimated and forecasted in
Pharmacy Automation Market Competitive Landscape, Growth Factors and Forecast 2019 to 2028
Pharmacy Automation Market Competitive Landscape, Growth Factors and Forecast 20 …
In the modern healthcare system, the automation in the pharmacy sector plays an important role, as it minimizes the errors during the manual processes including, missing drug information, missing patient information, formulation dispensing, prescription errors, and monitoring therapies. The wrong label instruction and information are major mistakes. As per the National Coordinating council for medication error reporting and prevention (NCC MERP), in U.S. approximately 100 million people die annually from

More Releases for Alzheimer

Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as